학술논문
PDB61 - Cost of Reaching Defined HbA1c Target Using Canagliflozin Compared to Dapagliflozin as Add-On to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) in the United Arab Emirates (UAE)
Document Type
Abstract
Author
Source
In Value in Health November 2015 18(7):A608-A608
Subject
Language
ISSN
1098-3015